44
https://pubmed.ncbi.nlm.nih.gov/38091664
Full primary COVID-19 vaccination in individuals with breakthrough infections caused by variants of concern reduces symptom frequencies and elicits a more rapid and longer-lasting neutralization capacity compared to unvaccinated individuals.
